Introduction
The adoption of minimally invasive techniques in rectal cancer surgery has been show to offer many advantages including less blood loss, earlier recovery of bowel function, shorter hospital stay, earlier return to daily activities, and better post-operative pain scores1,2. Thanks to the continuous innovation of laparoscopic instruments, laparoscopic colorectal surgery is being considered feasible nowadays instead of being technically demanding with a steep learning curve in the past3.
The standard method of inferior mesenteric vessels ligation during laparoscopic colorectal surgery is either laparoscopic staplers or vascular clips4. The introduction of new energy vessel sealing devices led to better hemostatic effect, less blood loss, and shorter operating time utilizing either radiofrequency in electro-thermal bipolar vessel sealers (EBVS), ultrasound in ultrasonic shears or even a combination with conventional bipolar energy5.
The advanced EBVS Ligasure® (Covidien, Mansfield, MA, USA) applies high current low voltage power that when combined with compression by the device jaws leads to collapse of the vessel wall with denaturation of its elastin and collagen that ends in vessel sealing6,7. This device can seal vessels up to 7 mm in diameters and these sealed vessels can withstand a systolic blood pressure 3 times the normal value8. The use of laparoscopic staplers or clips to ligate the inferior mesenteric vessels necessitates reloads, which might increase the operative time and costs of surgery. Unlike the EBVS which could also be used in control of bleeding from the omentum, mesentery, or retroperitoneum and to dissect the tissues which is suggested to decrease the instruments traffic9.
At present, the available evidence from literature about the use of EBVS in laparoscopic rectal cancer surgery is weak. Most of the studies recruited heterogeneous group of diseases (benign and malignant), heterogeneous types of surgeries (right, left-sided colectomies, and anterior resections), and even heterogeneous approaches to inferior mesenteric vessels ligation (EBVS 5 and 10 mm sizes, ultrasonic shears, vascular staplers, and clipping). In the present study, we tried to narrow our study population, where we retrospectively focused on operative safety and short-term outcome of laparoscopic rectal cancer surgery using either Ligasure® 5 mm or vascular clips to ligate the inferior mesenteric pedicle. We believed that this could attain more relevant results.
Methods
The present study was designed as a retrospective cohort study where forty rectal cancer patients operated by minimally invasive approaches (laparoscopic assisted or taTME with laparoscopic assistance) in two tertiary centers (Oncology Center Mansoura University, Egypt, and San Raffaele Hospital, Milan Italy) during a period of 25 months (April 2017-May 2019) were recruited. The patients were classified into two groups according to the method of vascular ligation either mechanical ligature group (n = 24) or EBVS group (n = 16). Demographic, operative, and post-operative data were collected from a prospectively maintained database in both centers. In case of missing data video recordings of the surgeries were reviewed and the operating surgeons were contacted, patients with any missing data were excluded from the study.
In all patients, a medial approach with high tie of the vascular pedicle was applied. The ligation and transection of the inferior mesenteric pedicle were accomplished after placing two clips – either titanium (Fig. 1A and B) or hemoclips (Fig. 2A and B) – proximally using a laparoscopic clip applier and one clip distally (Fig. 1C) then cutting in between in the mechanical ligature group. In the EBVS group Ligasure® 5 mm was used to seal the inferior mesenteric vessels after skeletonization of the vessel and visualization of the left ureter. Two device activations were performed proximally (Fig. 3A) and distally (Fig. 3B), and then the vessel was cut by the device’s knife in between (Fig. 3C).
Operations were performed by four surgical oncology consultants and a specialist in Oncology Center Mansoura University and three gastrointestinal surgery consultants in San Raffaele hospital.
The primary outcome of the study was the operative feasibility and safety of both techniques through comparing several variables: operative time (minutes), estimated blood loss (milliliters), the need for blood transfusion, operative complications, conversion, and post-operative complications (assessed by Clavien-Dindo Score). The secondary outcome included the short-term oncologic results in the form of: lymph node harvest, circumferential and longitudinal margins assessment, quality of total mesorectal excision, and recurrence events.
Statistical analysis
Analysis of the patients’ data was performed using SPSS (version 22). Naturally, distributed parameters were presented as mean and standard deviation; otherwise data are presented as median and range or percentage. Categorical variables were compared using Chi-square, while Mann–Whitney and Student t tests were used for parametric data.
Results
Forty cases were enrolled in this study. The mean age of the study patients was 53.2. Male predominates with 24 cases versus 16 female patients. The mean BMI of the study group was 28.2 (overweight). All cases were low to mid rectal cancer except for one case of upper rectal cancer.
In this study, 22 patients underwent laparoscopic total mesorectal excision (LTME), while 18 patients underwent transanal total mesorectal excision (taTME). Thirty-four patients (85%) received neoadjuvant therapy before proctectomy.
In 14 cases, advanced bipolar, namely, Ligasure® was employed in vascular control, in contrast to 26 patients where clipping was used for vascular control.
All cases underwent stoma, all loop ileostomy except three terminal colostomies. Morbidities occurred in 13 case, representing 32.5% of cases with one case of peri-operative mortality because of septic shock after necrotizing fasciitis of the Pfannenstiel incision (Table 1).
Parameter | Data |
---|---|
Age | 53.2 ± 12.5a |
BMI | 28.2 ± 6.6a |
Distance from verge | 5 (2-10)b |
Neoadjuvant therapy | 34 (85%) |
Long course CRT | 31 |
Short course RT | 1 |
CRT + Biologic therapy | 1 |
CT + Biologic therapy | 1 |
Metastasis | 4 (10%) |
Liver | 3 (7.5%) |
Inguinal lymph nodes | 1 (2.5%) |
Conversion to open | 4 (10%) |
Anastomosis method | |
EEA stapler | 18 |
Manual | 19 |
Tumour grade | |
I | 2 |
II | 31 |
III | 5 |
Pathologic T stage | |
0 | 5 |
1 | 4 |
2 | 11 |
3 | 19 |
4a | 1 |
N stage | |
0 | 26 |
1a | 4 |
1b | 6 |
2a | 1 |
2b | 3 |
Stage group | |
0 | 5 |
I | 12 |
II | 8 |
III | 11 |
IV | 4 |
CRM | Infiltrated 2 Free 37 (10 mm [1-25 mm])b |
DRM | Infiltrated 1 |
LVE | 7 |
PNI | 7 |
Response to NAT | |
0 | 5 |
1 | 5 |
2 | 10 |
3 | 14 |
aMean and standard deviation;
bMedian and range; BMI: body mass index (Kg/m2); CRT: chemoradiotherapy; CRM: circumferential resection margin; CT: chemotherapy; DRM: distal resection margin; EEA stapler: end-to-end anastomosis stapler;
LVE: lymphovascular emboli; PNI: perineural invasion. Response to NAT: response to neoadjuvant therapy according to College of American Pathologists (CAP).
Patients were divided into two groups according to the method of vascular pedicle control; Group 1 used advanced bipolar (EBVS group), while Group 2 used vascular clips (clip group). The statistical comparison of the two groups regarding basic epidemiologic, operative, and pathologic data revealed insignificant difference except for the BMI which was significantly higher in the EBVS group (mean difference 7.5) (Table 2).
Parameter | Group 1: Ligasure | Group 2: Clipping | p-valuea |
---|---|---|---|
Sex | 0.5 | ||
Male | 7 | 17 | |
Female | 7 | 9 | |
Ageb | 50.4 ± 10.4 | 54.8 ± 13.5 | 0.29 |
BMIb(Kg/m2) | 33.1 ± 7.6 | 25.6 ± 4.3 | 0.00 |
ASA | 0.35 | ||
I | 3 | 7 | |
II | 11 | 16 | |
III | 0 | 3 | |
Site of tumor | 0.16 | ||
Low | 9 | 12 | |
Middle | 4 | 14 | |
Upper | 1 | 0 | |
Neoadjuvant therapy | 0.07 | ||
No | 0 | 6 | |
Yes | 14 | 20 | |
Operation | 0.2 | ||
LAR | 2 | 4 | |
ULAR | 4 | 9 | |
ISR | 6 | 13 | |
APR | 2 | 0 | |
Minimally invasive Approach | 0.1 | ||
TaTME | 9 | 9 | |
LTME | 5 | 17 | 0.1 |
Pathology | 1 | ||
Conventional | 13 | 23 | |
adenocarcinoma | |||
Mucoid carcinoma | 1 | 3 | |
Grade | 0.71 | ||
I | 1 | 1 | |
II | 11 | 20 | |
III | 1 | 4 | |
Pathologic T | 0.53 | ||
0 | 2 | 3 | |
1 | 0 | 4 | |
2 | 4 | 7 | |
3 | 8 | 11 | |
4 | 0 | 1 | |
Pathologic n | 0.47 | ||
0 | 10 | 16 | |
1 | 2 | 8 | |
2 | 2 | 2 | |
Metastasis | 1 | ||
No | 13 | 23 | |
Yes | 1 | 3 | |
AJCC | 0.82 | ||
0 | 2 | 3 | |
I | 3 | 9 | |
II | 4 | 4 | |
III | 4 | 7 | |
IV | 1 | 3 | |
CRM | 1 | ||
Free | 12 | 25 | |
Infiltrated | 1 | 1 | |
DRM | 0.35 | ||
Free | 13 | 26 | |
Infiltrated | 1 | 0 | |
LVE | 1 | ||
No | 12 | 21 | |
Yes | 2 | 5 | |
PNI | 0.21 | ||
No | 10 | 23 | |
Yes | 4 | 3 | |
Response to NAC therapy (CAP grade) | 0.81 | ||
0 | 2 | 3 | |
1 | 2 | 3 | |
2 | 3 | 7 | |
3 | 7 | 7 | |
Quality of TME | 0.56 | ||
Incomplete | 0 | 1 | |
Near complete | 3 | 3 | |
Complete | 11 | 22 | |
Adjuvant therapy | 0.39 | ||
No | 1 | 6 | |
Yes | 10 | 18 |
ap value is considered significant if < 0.05 b Mean and standard deviation;
AJCC: American Joint Committee on Cancer; ASA: American Society of Anesthesiologists; APR: Abdomino-perineal resection; BMI: body mass index (Kg/m2); CRM: circumferential resection margin; LAR: low anterior resection; DRM: distal resection margin; ISR: intersphincteric resection; LTME: laparoscopic total mesorectal excision; LVE: lymphovascular emboli; PNS: perineural spread; ; TaTME: trans-anal total mesorectal excision; ULAR: ultralow anterior resection. Response to NAT: response to neoadjuvant therapy according to College of American Pathologists (CAP).
The two study groups were compared regarding operative and oncologic short outcomes and morbidity, as shown in table 3. The operative time was significantly longer (mean difference 103 min) and the blood loss was significantly more in the EBVS group. However, hospital stay, time to oral, time to starting stoma function and number of retrieved lymph nodes were not significantly affected by the method of vascular control. Moreover, complications related to autonomic nerve injury (bladder dysfunction, impotence, and retrograde ejaculation) occurred in two cases in the clip group and nil in the EBVS group.
Outcome | Group 1: Ligasure | Group 2: Clipping | p-valuea |
---|---|---|---|
Conversion to open | 0.11 | ||
No | 11 | 25 | |
Yes | 3 | 1 | |
Operative timeb(min) | 353.6 ± 65.7 | 250.6 ± 65.3 | 0.00 |
Blood lossc(milliliter) | 500 (220-650) | 200 (50-750) | 0.00 |
Time to oral (days) | 2.5 (1-4) | 2 (2-4) | 0.75 |
Function stomac(days) | 2 (1-3) | 2 (2-4) | 0.65 |
Hospital stay | 7.5 (3-18) | 7 (4-19) | 0.81 |
LN harvest | 9 (3-17) | 12.5 (2-42) | 0.21 |
LN infiltrated | 0 (0-14) | 0 (0-15) | 0.68 |
Peri-operative complications (CD) | 0.26 | ||
I | 1 | 0 | |
II | 1 | 4 | |
IIIa | 3 | 2 | |
IIIb | 0 | 1 | |
V | 1 | 0 | |
Functional nerve related complications | 0.53 | ||
No | 14 | 24 | |
Bladder dysfunction and impotence | 0 | 1 | |
Retrograde ejaculation | 0 | 1 | |
Recurrence events | 1 | ||
No | 12 | 23 | |
Yes | 2 | 3 |
ap value is considered significant if < 0.05;
bMean and standard deviation Median and range; LN: lymph node. Clavien Dindo’s scale
Discussion
The growing adoption of minimally invasive techniques in colorectal cancer surgery has led to an increasing need for safer, more efficient, reliable hemostasis, and tissue dissection10. Recent advances in technology of laparoscopic surgical instrumentation made laparoscopic colorectal surgery more feasible3.
There are several available options for control of the inferior mesenteric vascular pedicle. These include laparoscopic vascular staplers which are disposable and require reloads, clip appliers which may be single or multi-fire, disposable or reusable, and energy-based devices. The last two options are more commonly adopted by surgeons, but more skills might be needed in vascular clipping to avoid bleeding and longer operative duration9.
Ligasure 5 mm is an advanced EBVS which applies the main principle of conversion of electrical energy to mechanical energy to thermal energy to ensure vessel sealing without the risk of passage of electric current through the tissue5. In addition, it is a multifunctional device with blunt non-traumatic jaws which is considered an important advantage in complex laparoscopic colorectal surgery. This is because it allows the surgeon to use it throughout the surgery with efficient hemostatic ability which avoids the need for changing instruments and minimizes instruments traffic through the different steps of surgery11. The advantage of adding a cutting device in the Ligasure also minimizes the instrument traffic and this should have an impact on operative time and surgical costs12.
Advanced EBVS devices as Ligasure were approved by the United States food and drug administration to seal blood vessels up to 7 mm in diameter13. The duration needed for sealing a blood vessel is 10 s, this seal can withstand systolic blood pressure 3 times the normal value14. It is well known that the burst pressure for vascular stapling or clipping is higher than EBVS, but this is clinically irrelevant provided that both are above the physiologic level15.
In the present study, statistically significant higher mean operative time (353.6 vs.250.6 min, p = 0.00) and median blood loss (500 vs. 200 milliliters, p = 0.00) were reported in the EBVS group than in the clipping group. These results are different from those reported by Marcello et al. where they compared both approaches in cases of right, left colectomies, sigmoidectomies, and total colectomies. They found higher mean operative time and blood loss in the clipping group than the EBVS group, but in his study the differences were not statistically significant. They used Ligasure 10 mm for vascular pedicle ligation in the EBVS group, and they included benign and malignant cases9. This can be explained by the higher BMI in the EBVS group in the current study; this coincides with a meta-analysis adopted by Fung et al., who reported increased operative time and increased incidence of peri-operative complications including more estimated blood loss in obese patients who underwent laparoscopic colorectal surgery16. Furthermore, the operating surgeons may have chosen EBVS rather than clipping in difficult prolonged procedures in trial to cut down the operative time.
Another merit of advanced EBVS is the pulsatile electrical energy delivery along with computer-controlled tissue feedback response which decreases the risk of lateral thermal spread. Moreover, it avoids the possibility of high tissue temperature, lateral thermal spread, tissue charring, and adhesion to the instrument jaws thanks to the automatic shut-down feature once the desired tissue sealing was accomplished5.
In their study, Trilling et al. reported comparable minor complications events (CD I-II) in both groups of energy devices or clipping of inferior mesenteric vessels during laparoscopic sigmoidectomy for diverticulitis. Major events (CD III-V) were reported more in mechanical ligature group, but these results were statistically insignificant. Conversion to open was not significantly higher in the mechanical ligature group17. In our study, minor complications were insignificantly higher in the clipping group, while the major complications were nearly comparable in both groups. Conversion to open was insignificantly higher in the EBVS group.
It is worth mentioning that every energy device has its own advantages and disadvantages. This could explain the lack of strong evidence about their use. Moreover, factors such as personal preference, surgical learning curve and training, availability, cost of the energy devices, and familiarity of the surgeon with them could explain the contradictory results and weak evidence from the previously reported studies18.
The present study has some limitations such as the retrospective nature, non-reporting of long-term functional results, and the recruitment of patients operated by heterogeneous group of surgeons in two different hospitals which could have an impact on the reported results due to difference in surgical technique or learning curve. Moreover, significantly higher BMI was reported in the EBVS group which could have affected some operative results as operative time and blood loss. To sum up, we tried to present better quality of reported results through narrowing of the study population focusing on surgery for rectal cancer patients and reporting data on oncologic outcome which was deficient in previous studies.
Conclusion
Controlling of the inferior mesenteric vessels using EBVS and clipping has comparable results regarding safety, feasibility, and short-term oncologic outcomes. It mainly depends on surgeon’s preference and experience which method to choose for control of vascular pedicle during minimally invasive rectal cancer surgery. Prospective well-designed trials are awaited to provide stronger evidence regarding the best approach for colorectal vascular pedicle ligation.